SYF0f24a0755a59457a86009f5c37337f89Registry ID: 2024-517068-43-00|UnknownPhase 4Results
Loading search results
interventional
N/A
1 country
1
Tutkimuksen tavoitteena on ensimmäisessä vaiheessa selvittää poikkeavan lihasaktiivisuuden esiintymistä rinta- ja lannerangan alueen lihaksissa servikaalista dystoniaa sairastavilla henkilöillä sekä toisessa vaiheessa kaksoissokkoutetusti tutkia botuliinitoksiinihoidon tehoa ja mahdollisia sivuvaikutuksia selkälihaspistoksista niillä tutkittavilla, joilla on poikkeava selän alueen aktiivisuus.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 19, 2024
Actual (reported)Dystonian vaikeusasteen muutosta Unified dystonia rating scale (UDRS, Liite I) -asteikon avulla.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
Botox 50 Allergan-yksikköä Injektiokuiva-aine, liuosta varten
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
SOLUTION FOR INJECTION
View registry recordFormulated product
Botox 100 Allergan-yksikköä Injektiokuiva-aine, liuosta varten
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
SOLUTION FOR INJECTION
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
Botox 50 Allergan-yksikköä Injektiokuiva-aine, liuosta varten
Named ingredient: Botulinum toxin type a
View registry recordBotox 100 Allergan-yksikköä Injektiokuiva-aine, liuosta varten
Named ingredient: Botulinum toxin type a
View registry recordPirkanmaan hyvinvointialue
Tampere, 33520, Finland
Rebekka Ortiz
First Submitted
August 19, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.